Peptides May Soon Be Legal. These Companies Are Ready to Cash In
Originally on
Forbes · hosted by Forbes
The guest
Amy Feldman
Forbes journalist; author of the accompanying story
A Forbes journalist whose reporting on compounding pharmacies and telehealth companies preparing for legal peptides underpins this video.
In this episode
- Why an FDA panel could open legal production of as many as seven peptides
- How compounding pharmacies such as Empower are preparing for the vote
- Why the gray market for BPC-157 and TB-500 could be worth an estimated $3 billion
- Why telehealth founders expect a "Wild West" for the first six months
Listen & watch
Keep listening
